Luigino Calzetta Selected Research

Albuterol (Salbutamol)

1/2021	Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study.
1/2020	A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study.
1/2019	Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis.
12/2018	Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2).
1/2018	Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
4/2011	Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luigino Calzetta Research Topics

Disease

116	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 04/2010
78	Asthma (Bronchial Asthma) 02/2024 - 04/2010
19	Inflammation (Inflammations) 02/2024 - 04/2010
8	Pneumonia (Pneumonitis) 01/2024 - 05/2017
8	COVID-19 01/2023 - 01/2020
7	Respiratory Hypersensitivity 12/2022 - 03/2012
6	Lung Diseases (Lung Disease) 07/2023 - 03/2012
4	Airway Obstruction (Choking) 02/2024 - 10/2017
4	Chronic Cough 01/2024 - 07/2016
4	Hypersensitivity (Allergy) 10/2023 - 01/2016
4	Chronic Bronchitis 06/2022 - 09/2015
4	Heart Failure 01/2020 - 09/2010
3	Bronchial Spasm 01/2023 - 06/2013
3	Dyspnea (Shortness of Breath) 01/2022 - 12/2013
2	Infections 01/2024 - 01/2019
2	Diabetes Mellitus 02/2023 - 12/2014
2	Headache (Headaches) 01/2018 - 08/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 09/2010
2	Hypoxia (Hypoxemia) 12/2013 - 09/2010

Drug/Important Bio-Agent (IBA)

47	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 05/2011
26	Muscarinic AntagonistsIBA 01/2023 - 05/2011
25	Bronchodilator Agents (Bronchodilators)IBA 02/2024 - 09/2011
13	Monoclonal AntibodiesIBA 01/2024 - 04/2015
10	Cholinergic Agents (Cholinergics)IBA 06/2022 - 08/2015
10	Tiotropium Bromide (Spiriva)FDA Link 06/2022 - 09/2010
9	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2023 - 05/2011
8	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 06/2022 - 12/2014
8	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 04/2015
7	CytokinesIBA 02/2024 - 04/2010
7	benralizumabIBA 01/2024 - 09/2017
7	ensifentrineIBA 12/2023 - 11/2013
7	indacaterolIBA 01/2022 - 07/2012
6	mepolizumabIBA 01/2024 - 09/2017
6	fluticasone furoate FDA Link 12/2023 - 07/2016
6	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2016
6	Formoterol Fumarate (Oxis)FDA Link 04/2021 - 10/2015
6	Albuterol (Salbutamol)FDA LinkGeneric 01/2021 - 04/2011
6	Expectorants (Mucolytics)IBA 11/2020 - 01/2017
6	Acetylcysteine (Siran)FDA LinkGeneric 05/2019 - 09/2015
5	vilanterolIBA 12/2023 - 07/2012
5	AllergensIBA 10/2023 - 01/2016
5	Interleukin-5 (Interleukin 5)IBA 01/2023 - 01/2018
5	reslizumabIBA 07/2021 - 09/2017
5	doxofyllineIBA 01/2020 - 01/2018
4	dupilumabIBA 01/2024 - 01/2019
4	Omalizumab (Xolair)FDA Link 01/2024 - 01/2019
4	GSK573719IBA 12/2023 - 12/2014
4	SteroidsIBA 02/2023 - 08/2018
4	Beclomethasone (Beclometasone)FDA Link 04/2021 - 12/2018
4	Theophylline (Theon)FDA LinkGeneric 01/2019 - 01/2018
4	Phosphodiesterase 4 InhibitorsIBA 08/2016 - 11/2013
3	mesoglycanIBA 02/2024 - 01/2022
3	Oxidants (Oxidizing Agents)IBA 02/2024 - 01/2016
3	Thymic Stromal LymphopoietinIBA 01/2024 - 04/2020
3	tezepelumabIBA 01/2024 - 04/2020
3	SmokeIBA 10/2023 - 09/2012
3	Interleukin-13IBA 05/2023 - 04/2020
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2023 - 07/2015
3	ChemokinesIBA 01/2023 - 09/2016
3	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2022 - 01/2021
3	LipopolysaccharidesIBA 01/2022 - 01/2017
3	GlucocorticoidsIBA 12/2020 - 01/2014
3	erdosteineIBA 11/2020 - 01/2018
3	tiotropium-olodaterolIBA 01/2020 - 04/2016
3	Therapeutic UsesIBA 01/2020 - 09/2016
3	AntioxidantsIBA 05/2019 - 01/2017
3	RoflumilastIBA 01/2018 - 07/2016
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2016 - 09/2010
3	Oxygen (Dioxygen)IBA 12/2013 - 09/2010
2	EnzymesIBA 07/2023 - 03/2012
2	Phosphotransferases (Kinase)IBA 05/2023 - 07/2015
2	BNT162 VaccineIBA 01/2023 - 03/2021
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2023 - 01/2020
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2023 - 11/2018
2	Cholinergic ReceptorsIBA 06/2022 - 01/2021
2	Capsaicin (Zostrix)FDA Link 01/2022 - 12/2011
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2022 - 10/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2019
2	Humanized Monoclonal AntibodiesIBA 09/2021 - 09/2017
2	Immunoglobulin E (IgE)IBA 09/2021 - 10/2017
2	Budesonide (Pulmicort)FDA LinkGeneric 04/2021 - 01/2016
2	GoldIBA 07/2020 - 08/2015
2	XanthineIBA 06/2018 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2017 - 06/2012
2	Angiotensin II Type 1 Receptor BlockersIBA 05/2017 - 06/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2017 - 06/2012
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 10/2012
2	Adenosine Monophosphate (AMP)IBA 07/2016 - 03/2012
2	olodaterolIBA 04/2016 - 07/2012
1	AerosolsIBA 02/2024

Therapy/Procedure

82	Therapeutics 02/2024 - 09/2010
15	Nebulizers and Vaporizers (Inhaler) 12/2023 - 09/2011
5	Biological Therapy 01/2024 - 01/2018
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
3	Precision Medicine 09/2021 - 01/2017
2	Investigational Therapies (Experimental Therapy) 09/2022 - 07/2020
2	Duration of Therapy 12/2020 - 01/2017
1	Off-Label Use 01/2024